That's a wrap! Thank you delegates, faculty, supporters, partners and sponsors for making the virtual #HCV2021 a resounding success! #HCV#HepatitisC#HepC
A special thank you to the #HCV2021 International Advisory Committee, the custodians of this leading international scientific meeting #HCV#HepatitisC#HepC
As we begin our closing ceremony, please join us in congratulating our Meeting Co-Chairs for their outstanding leadership in the development and delivery of #HCV2021@naglaa_shoukry@JJFeld Daniel LaMarre πππ #HCV#HepatitisC#HepC
So proud to see no less than two of our first-author participants receiving the @VirusesMDPI award at #HCV2021@HCV2021 : Raphael Wolfisberg and Joy Tomlinson @JoyTomlinson7 Check out their presentations on animal models if you haven't already!
So proud to see no less than two of our first-author participants receiving the @VirusesMDPI award at #HCV2021@HCV2021 : Raphael Wolfisberg and Joy Tomlinson @JoyTomlinson7 Check out their presentations on animal models if you haven't already!
Great talk by @argonne Eric Tatara on Re-treatment with direct-acting antivirals - policy is needed to eliminate Hepatitis C among persons who inject drugs. #HCV2021#HCV#elimination#HepC#HepatitisC
Call for abstracts closes Friday July 9th for the 2021 International HBV Meeting in Toronto, Canada. This yearβs meeting will take place September 26-30, 2021 both virtually and in-person. Please visit https://t.co/qL9bc86lxo for more information!
#hbv#hepatitisb#hepb